Storage of tissue-type plasminogen activator in Weibel-Palade bodies of human endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1796-1803

  Rosnoblet, Corinne ^b   Vischer, Ulrich M ^b   Gerard, Robert D ^b   Irminger, Jean Claude ^b   Halban, Philippe A ^b   Kruithof, Egbert K O ^a  

^a University Hospital   (Switzerland)

^b NONE

Author keywords

Endothelial cells; Immunofluorescence; Tissue type plasminogen activator; von Willebrand factor; Weibel Palade bodies

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTICLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; TISSUE DISTRIBUTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0033063101     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1796     Document Type: Article

References (39)

1. Kristensen P, Larsson LI, Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Danø K. Human endothelial cells contain one type of plasminogen activator. FEBS Lett. 1984;168:33-37.
2. Larsson A, Astedt B. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. J Clin Pathol. 1985; 38:140-145.
3. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol. 1994;144: 855-861.
4. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1995;15:1444-1455.
5. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci. 1992;667:249-258.
6. Chandler WL, Levy WC, Stratton JR. The circulatory regulation of tPA and uPA secretion, clearance and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation. 1995;92: 2984-2994.
7. Giles AR, Nesheim ME, Herring SW, Hoogendoorn H, Stump DC, Heldebrant CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemost. 1990;63: 476-481.
8. Kruithof EKO, Mestries JC, Gascon MP, Ythier A. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation: effect of interleukin 6. Thromb Haemost. 1997;77:905-910.
9. Klöcking HP, Markwardt F. Pharmacological stimulation of t-PA release. Pharmazie. 1994;49:227-230.
10. Tranquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemost. 1990;63:454-458.
11. Tranquille N, Emeis JJ. On the role of calcium in the acute release of tissue-type plasminogen activator and von Willebrand factor from the rat perfused hindleg region. Thromb Haemost. 1991;66:479-483.
12. Wagner DD. The Weibel Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 1993;70:105-110.
13. Nilsson IM, Vilhardt H, Holmberg L, Astedt B. Association between tactor VIII related antigen and plasminogen activator. Acta Med Scand. 1982;211:105-112.
14. Vischer UM, Ingerslev J, Wollheim CB, Mestries JC, Tsakiris DA, Haefeli WE, Kruithof EKO. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) levels. Thromb Haemost. 1997;77:387-393.
15. van den Eijnden-Schrauwen Y, Kooistra T, de Vries REM, Emeis JJ. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood. 1995;85:3510-3517.
16. Casonato A, Sartori MT, Pontara E, Zucchetto A, Dannhauser D, Patrassi G, Girolami A. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content. Blood Coagul Fibrinolysis. 1992;3: 149-153.
17. Wieczorek I, Ludlam CA, MacGregor IR. Study of the endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. Blood Coagul Fibrinolysis. 1994;5:329-334.
18. Smalley DM, Fitzgerald JE, O'Rourke J. Adenosine diphosphate stimulates the endothelial release of tissue-type plasminogen activator but not von Willebrand factor from isolated-perfused rat hind limbs. Thromb Haemost. 1993;70:1043-1048.
19. van den Eijnden-Schrauwen Y, Atsma DE, Lupu F, de Vries REM, Kooistra T, Emeis JJ. Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:2177-2187.
20. Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Wesmuckett A, Lupu F. An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol. 1997;139:245-256.
21. Moore HPH, Kelly RB. Secretory protein targeting in a pituitary cell line: differential transport of foreign secretory proteins to distinct secretory pathways. J Cell Biol. 1985;101:1773-1781.
22. DeClerck PJ, Lijnen R, Verstreken M, Moreau H, Collen D. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of clot lysis with single-chain urokinase-type plasminogen activator in plasma. Blood. 1990;75: 1794-1800.
23. DeClerek PJ, Van Keer L, Verstreken M, Collen D. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA. Thromb Haemostas. 1992;67:95-100.
24. Kobayashi T, Stang E, Fang KS, de Moerloose P, Parton RG, Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature. 1998;392:193-197.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973;52:2745-2756.
26. Carmeliet P, Stassen JM, van Vlaenderen I, Meidell RS, Collen D, Gerard RD. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood. 1997;90: 1527-1534.
27. Carmeliet P, Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation. 1997;96:3180-3191.
28. Irminger JC, Meyer K, Halban P. Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirtis. Biochem J. 1996;320:11-15.
29. Gerard RD, Meidell RS. Adenovirus vectors. In: Hames BD, Glover D, eds. DNA Cloning-A Practical Approach: Mammalian Systems. Oxford, UK: Oxford University Press: 1995:285-306.
30. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol. 1982;95:355-360.
31. Louvard D, Reggio H, Warren G. Antibodies to the Golgi complex and the rough endoplasmic reticulum. J Cell Biol. 1982;92:92-107.
32. Ribes JA, Francis CW, Wagner DD. Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest. 1987;79:117-123.
33. Levin EG, Santell L, Osborn KG. The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location. J Cell Sci. 1997;110:139-148.
34. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression In vivo. Blood. 1998;92:2791-2801.
35. Rosenberg JB, Foster PA, Kaufman RJ, Vokac EA, Moussalli M, Kroner PA, Montgomery RR. Intracellular trafficking of factor VIII to von Willebrand factor storage granules. J Clin Invest. 1998;101:613-624.
36. Harrison TM, Chidgey MAJ, Uff S. Novel markers for constitutive secretion used to show that tissue plasminogen activator is sorted to the regulated pathway in transfected PC12 cells. Cell Biol Int. 1996;20: 293-300.
37. Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem. 1997;272:1976-1982.
38. Kaufmann JE, Irminger JC, Mungall J, Halban PA. Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes. 1997;46:978-982.
39. Ozaka T, Doi Y, Kayashima K, Fujimoto S. Weibel-Palade bodies as a storage site of calcitonin gene-related peplide and endothelin-1 in blood vessels of the rat carotid body. Anat Rec. 1997;247:388-394.